Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ENYO Pharma is a clinical stage Biotech with a unique drug discovery engine inspired by viruses. The company is currently entering Phase 2 with its lead compound EYP001 (a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH.Several additional innovative drug discovery programs are progressing speedily towards non-Clinical Development; their human targets being yet untapped by Pharma’s, these programs can moreove...
ENYO Pharma is a clinical stage Biotech with a unique drug discovery engine inspired by viruses. The company is currently entering Phase 2 with its lead compound EYP001 (a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH.Several additional innovative drug discovery programs are progressing speedily towards non-Clinical Development; their human targets being yet untapped by Pharma’s, these programs can moreover be developed for various indications

List your booth number for exhibitions, ask us